Selcuk University
Konya, Selcuklu, 42130, Turkey (Türkiye)
NCT Number: NCT06036173
To determine whether body awareness and upper extremity functionality are affected in patients with or without lymphedema development after breast cancer surgery in comparison with individuals without a history of cancer.
Looking for future studies?
Notify Me18 year–65 year
Female
Observational
Konya, Selcuklu, 42130, Turkey (Türkiye)
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
first group:
second group:The inclusion criteria for the breast cancer surgery group
Lastly, the inclusion criteria for the control group were:
Exclusion criteria
for all groups
being diagnosed with secondary lymphedema in the upper extremity according to the International Lymphedema Association
be diagnosed and undergo surgery
Time frame: 17 minutes
This instrument consists of a total of 18 items evaluated based on a scale of 1 (not at all true of me) to 7 (very true of me). The total score is obtained by adding the scores of each item. A higher total score indicates better body awareness. Max/ min score:126/18
Time frame: 11 minutes
Each of the 11 items in this instrument is scored from 1 to 5. The responses given to all items are summed up, and the total score is obtained with a special formula. A high total score indicates a high level of functional limitation. Max/ min score: 100/0
Selcuk University
Other
Effects of Lymphedema After Breast Cancer Treatment on Body Awareness and Upper Extremity Functionality
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06012786
Breast Cancer, Breast Cancer Female
Istanbul, Kadıköy, Turkey (Türkiye)
View Trial DetailsNCT06606145
Hemic and Lymphatic Diseases, Lymphatic Diseases
Jette, Brussel Capital, Belgium
View Trial DetailsNCT06568978
Hemic and Lymphatic Diseases, Lymphatic Diseases
Tuzla, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06399458
Hemic and Lymphatic Diseases, Lymphatic Diseases
Istanbul, Ataşehir, Turkey (Türkiye)
View Trial Details